tickrz reports
  
tickrz rank
B
Cardinal Health Inc (CAH)
Services | Drugs Wholesale
CEO: George S. Barrett
Employees: 26500
cardinalhealth.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank72Dividend Rank155
Moat Rank167Financial Strength Rank85
Growth Rank205Momentum Rank430
DIVIDEND ANALYSIS
Dividend Yield2.44%
Payout Ratio41.52%
3 yr Dividend Growth13.88%
VALUATION RATIOS
P/E Ratio17.36x
P/B Ratio3.52x
P/S Ratio0.18x
EV/EBITDA Ratio9.19x
FINANCIAL STRENGTH
Piotroski F-Score7
Debt-to-Equity81%
Interest Coverage12.87x
MOAT
ROE19.83%
ROIC14.16%
Net Margin1.17%
GROWTH
5 yr EPS Growth9.69%
5 yr SPS Growth3.44%
5 yr BPS Growth4.09%
Cardinal Health Inc achieves a strong Pure Value rank with its low valuation multiples
 tickrz summary
Cardinal Health Inc receives a B ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cardinal Health Inc's valuation score is comprised of a P/E ratio of 17.4x, a P/B ratio of 3.5x, a P/S ratio of 0.2x, and an EV/EBITDA ratio of 9.2x. Cardinal Health Inc ranks 72 out of the S&P 500 constituents on valuation--a relatively strong score.Cardinal Health Inc ranks 28 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cardinal Health Inc warrants further investigation.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.Cardinal Health Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 12.87x, a debt/equity ratio of 81% and a Moat Rank of 167 translate to a strong Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -6.22% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 430. Based on its 12 month stock performance, Cardinal Health Inc will not appeal to momentum investors.

 yield
 value + yield
Shares currently yield 2.44%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cardinal Health Inc ranks 155 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 9.7% 5 year annualized EPS growth, 3.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 4.1% combine to produce this average score.

Cardinal Health Inc (CAH)
Services | Drugs Wholesale
CEO: George S. Barrett
Employees: 26500
cardinalhealth.com


tickrz rank
B

VALUATION RATIOS
P/E Ratio17.36x
P/B Ratio3.52x
P/S Ratio0.18x
EV/EBITDA Ratio9.19x
DIVIDEND ANALYSIS
Dividend Yield2.44%
Payout Ratio41.52%
3 yr Dividend Growth13.88%
FINANCIAL STRENGTH
Piotroski F-Score7
Debt-to-Equity81%
Interest Coverage12.87x
MOAT
ROE19.83%
ROIC14.16%
Net Margin1.17%
GROWTH
5 yr EPS Growth9.69%
5 yr SPS Growth3.44%
5 yr BPS Growth4.09%

TICKRZ RANK
Cardinal Health Inc receives a B ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cardinal Health Inc's valuation score is comprised of a P/E ratio of 17.4x, a P/B ratio of 3.5x, a P/S ratio of 0.2x, and an EV/EBITDA ratio of 9.2x. Cardinal Health Inc ranks 72 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Cardinal Health Inc ranks 28 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cardinal Health Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
Cardinal Health Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 12.87x, a debt/equity ratio of 81% and a Moat Rank of 167 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -6.22% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 430. Based on its 12 month stock performance, Cardinal Health Inc will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 2.44%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cardinal Health Inc ranks 155 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 9.7% 5 year annualized EPS growth, 3.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 4.1% combine to produce this average score.